Low-dose metformin and PEN2-dependent lysosomal AMPK activation: benefits outnumber side effects
Crossref DOI link: https://doi.org/10.1038/s41392-022-01040-9
Published Online: 2022-06-04
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Liu, Longlong
Patnana, Pradeep Kumar
Nimmagadda, Subbaiah Chary
Text and Data Mining valid from 2022-06-04
Version of Record valid from 2022-06-04
Article History
Received: 1 April 2022
Revised: 17 May 2022
Accepted: 25 May 2022
First Online: 4 June 2022
Competing interests
: The authors declare no competing interests.